SCHEMBL6708772

SCHEMBL6708772

O=C(Cc1ccc(-c2ccccc2)cc1)Nc1cccc2cc(C(=O)Nc3ccc(Cl)cc3-c3noc(=O)[nH]3)[nH]c12

nearest known ligand 0.42

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
PARP14 Q460N5 3/20 0.42
GRIK1 P39086 1/20 0.39
SERPINE1 P05121 1/20 0.39
KDM4E B2RXH2 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38
RXFP1 Q9HBX9 1/20 0.38
MEN1 O00255 1/20 0.38
ALDH1A1 P00352 1/20 0.38
POLB P06746 1/20 0.38
HPGD P15428 1/20 0.38
KMT2A Q03164 1/20 0.38
TP53 P04637 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
PLCG2 P16885 1/20 0.37
NR1H4 Q96RI1 1/20 0.37
BRD4 O60885 1/20 0.36
HDAC1 Q13547 1/20 0.36
NHERF1 O14745 1/20 0.36
RORC P51449 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6709861 0.95 GRIK1 (0.41) PARP14GRIK1KDM4EMEN1ALDH1A1
SCHEMBL6713394 0.94 PARP14 (0.42) PARP14GRIK1KDM4EMEN1ALDH1A1
SCHEMBL6707991 0.92 PTK2B (0.41) PARP14GRIK1KDM4EMEN1ALDH1A1
SCHEMBL6710325 0.92 RXFP1 (0.40) PARP14GRIK1RXFP1MEN1POLB
SCHEMBL6707625 0.92 GSK3A (0.41) PARP14GRIK1MEN1POLBKMT2A
SCHEMBL6713155 0.91 SERPINE1 (0.48) GRIK1SERPINE1KDM4ENPSR1RXFP1
SCHEMBL6708656 0.91 GRIK1 (0.37) PARP14GRIK1MEN1KMT2ANR1H4
SCHEMBL6708770 0.91 GRIK1 (0.41) PARP14GRIK1MEN1ALDH1A1POLB
SCHEMBL6711858 0.90 PTK2B (0.39) PARP14GRIK1SERPINE1ALDH1A1TP53
SCHEMBL6712528 0.90 GRIK1 (0.39) PARP14GRIK1TP53PLCG2NHERF1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040142981-A1 Antibacterial benzoic acid derivatives PHARMACIA & UPJOHN COMPANY 2004-07-22 US disclosed
WO-2004018461-A2 ANTIBACTERIAL BENZOIC ACID DERIVATIVES PHARMACIA & UPJOHN COMPANY LLC (US) 2004-03-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040142981-A1 Antibacterial benzoic acid derivatives GABRD, PHB1, GABBR1 PARP14 2597/4885GRIK1 3885/4885SERPINE1 2108/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.